American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of tumor immune biomarkers with pathologic complete response (pCR) in patients receiving atezolizumab + chemotherapy in early triple negative breast cancer (eTNBC): Exploratory analyses from the IMpassion031 study
    Meeting Abstract

    Molinero, L. L.; Mittendorf, E. A.; Zhang, H.; Barrios, C. H.; Saji, S.; Jung, K. H.; Patel, S.; Chang, C. W.; Liste-Hermoso, M.; Chui, S. Y.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase 2, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumors
    Meeting Abstract

    Gettinger, S.; Kluger, H.; Schoenfeld, A.; Betof-Warner, A.; He, K.; Sukari, A.; de Speville Uribe, B. D.; Lee, S.; Haefliger, S.; Goldberg, Z.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Batch effects in tumor biomarker studies using tissue microarrays: Extent, impact, and remediation
    Meeting Abstract

    Stopsack, K. H.; Wang, M.; Tyekucheva, S.; Gerke, T. A.; Vaselkiv, J. B.; Penney, K. L.; Kantoff, P. W.; Finn, S. P.; Fiorentino, M.; Loda, M.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Clinical validation of plasma cell-free DNA (cfDNA) sequencing in the phase 2 trial of sotorasib in patients (pts) with KRAS p.G12C mutated NSCLC
    Meeting Abstract

    Bauml, J. M.; Li, B. T.; Velcheti, V.; Govindan, R.; Fontecedro, A. C.; Dooms, C.; Takahashi, T.; Duda, A. W.; Odegaard, J.; Cruz-Guilloty, F.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Efficacy of atezolizumab in the treatment of solid tumors with high tumor mutational burden (TMB): A MyPathway study cohort
    Meeting Abstract

    Hainsworth, J.; Friedman, C. F.; Kurzrock, R.; Spigel, D. R.; Burris, H.; Sweeney, C. J.; Meric-Bernstam, F.; Wang, Y.; Levy, J.; Shames, D.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Kinetics of radiographic response for tebentafusp (tebe) in previously treated metastatic uveal melanoma (mUM) patients (pts) achieving prolonged survival
    Meeting Abstract

    Butler, M. O.; Sato, T.; Carvajal, R. D.; Sacco, J. J.; Abdullah, S. E.; Holland, C.; Goodall, H.; Shoushtari, A. N.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced renal cell carcinoma (RCC) who progressed on PD-1/L1 and VEGF inhibitors
    Meeting Abstract

    Hammers, H.; Choueiri, T.; Plimack, E.; Rini, B.; Motzer, R.; Yin, L.; Perini, R.; Willemann-Rogerio, J.; Albiges, L.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Urothelial cancer-GENOmic analysis to improve patient outcomes and research (UC-GENOME): A bladder cancer advocacy network (BCAN) led collaborative research study
    Meeting Abstract

    Damrauer, J. S.; Klomp, J.; Beck, W.; Zhou, M.; Plimack, E.; Galsky, M.; Grivas, P.; Hahn, N.; O'Donnell, P.; Iyer, G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Reclassification of ER+ (luminal A/luminal B1 minus ER low)-like and ER- like breast tumors based on proteomic/gene and clinical outcome signatures
    Meeting Abstract

    Wang, G.; Shah, P.; Searfoss, R.; Fantacone-Campbell, L.; Hooke, J. A.; Deyarmin, B.; Zingmark, R. N.; Somiari, S.; Liu, J.; Kvecher, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Development of Evidence Statement curation algorithms to aid cancer variant interpretation
    Meeting Abstract

    Saliba, J.; Sheta, L.; Krysiak, K.; Danos, A.; Marr, A.; Barnell, E.; Pema, S.; Lin, W. H.; Terraf, P.; McMichael, J. F.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: